Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

pegaspargase MeSH Supplementary Concept Data 2025


MeSH Supplementary
pegaspargase
Unique ID
C042705
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C042705
Entry Term(s)
Oncaspar
PEG-asparaginase
pegylated asparaginase
pegylated-L-asparaginase
polyethyleneglycol-asparaginase
Pharm Action
Antineoplastic Agents
Registry Numbers
7D96IR0PPM
0
Heading Mapped to
*Asparaginase
*Polyethylene Glycols
Frequency
322
Note
covalent attachment of PEG to enzyme produces active, stable complex; non-immunogenic; used in treatment of leukemia
Source
Cancer Biochem Biophys 1984;7(2):175
Indexing Information
Delayed-Action Preparations
Enzymes, Immobilized
Date of Entry
1984/10/10
Revision Date
2017/02/06
pegaspargase Preferred
Oncaspar Narrower
pegylated-L-asparaginase Narrower
page delivered in 0.004s